chevron_leftBack
As of 19 June 2026, Hemab Therapeutics Holdings, Inc. has a market cap of $1.37B USD, ranking #8991 globally and #1963 in the United States.
It ranks #766 in the Healthcare sector, and #147 in the Biotechnology industry.
Key Stats
Market Cap
$1.37BUSD
Company Profile
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 11% | 14% | 7.7% | -5.3% | -5.3% | -5.3% |
News
Loading...
COAG Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
COAG
ISIN: US4234941031
Shares Out.:
Shares Outstanding:
46.705M1
Shares Float:
33.257M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
29.24 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
13K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
12K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
2K%
|
-
|
|
NYSE: IQV
|
$26.3B
2K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
2K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
1K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.76B
3K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.7B
3K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.44B
3K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.29B
3K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.03B
2K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
2K%
|
-
|
chevron_leftBack